ASSOCIATE PROF. DR. ADLINDA BINTI ALIP
Department of Oncology Clinical
Faculty of Medicine
adlindaum.edu.myView CV | |
Publons | |
Scopus Link | |
Biography | |
Dr Adlinda graduated from Southampton University, UK and completed general medical training before being awarded the MRCP by the Royal College of Physician, UK. She obtained FRCR by the Royal College of Radiologist (Clinical Oncology) UK and awarded certificate of completion (CCT) in Clinical Oncology by General Medical Council UK in 2011. She joined University of Malaya as a Senior Lecturer and Clinical Oncologist in 2012. She is a principal and sub investigator for several ongoing and completed clinical trials. She gives talks and presentation locally and in international meetings. Her main areas of interest include Lung, Breast, Genitourinary and Stereotactic Radiosurgery/Radiotherapy. |
Publication
Finance
The outcomes of glioblastoma multiforme: The University Malaya Medical Centre experience 2008-2018
Amivantamab plus lazertinib vs osimertinib as first-line treatment in patients with EGFR-mutated, advanced nonsmall cell lung cancer (NSCLC): Primary results from MARIPOSA, a phase III, global, randomized, controlled trial
Evaluation of intrafractional prostate displacement during prostate radiotherapy using real-time ultrasound system
Evaluation of intrafractional prostate displacement during prostate radiotherapy using real-time ultrasound system
Amivantamab Plus Lazertinib vs Osimertinib as First-line Treatment Among Asian Patients With EGFR-mutated, Advanced Non-small Cell Lung Cancer (NSCLC): MARIPOSA Subgroup Analysis
Amivantamab Plus Lazertinib vs Osimertinib as First-line Treatment in Patients With EGFR-mutated, Advanced Non-small Cell Lung Cancer (NSCLC): Primary Results From MARIPOSA, a Phase 3, Global, Randomized, Controlled Trial
Abiraterone in metastatic castrate resistant prostate cancer: outcome and tolerance in real-world setting.
Diagnostic Dilemma: A case of Metastatic Tubulocystic Carcinoma of the Kidney.